Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
0.00%
)
US TECH 100
26,641.20
(
0.67%
)
Dow Jones
48,861.81
(
0.00%
)
Brent Oil
109.39
(
-2.66%
)
Bitcoin
76,317.42
(
0.71%
)
News Focus
News Focus
Post# of 517656
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ExtremelyBullishZig

Send PM Follow Ignore
Followers 43
Posts 10953
Boards Moderated 0
Alias Born 05/12/2006

ExtremelyBullishZig

Re: JWC3 post# 383810

Thursday, 11/17/2022 11:57:36 AM

Thursday, November 17, 2022 11:57:36 AM

Post# of 517656
How?...Around 6% will be improving. You can't even take the 2 of 32 people in the P2a trial and compare it to 509, because no one was on a placebo in the P2a. You have to take that percentage and use it compared to those not on a placebo in the P2b. 338 people not on a plaebo...

That means 21 people "may" see a benefit. That is only true if the 2 people that had an effect were diagnosed properly.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News